Targeted Genetics Aims To Reinitiate Arthritis Gene Therapy Trial By December
This article was originally published in The Pink Sheet Daily
Executive Summary
Data reviewed by NIH Recombinant DNA Advisory Committee suggest it is unlikely the experimental therapy contributed to a patient’s death in July, CEO says.